# Use of Lactate-to-Albumin, CRP-to-Albumin, and Procalcitonin-to-Albumin Ratios to Predict Mortality in ICU Patients

> **NCT07242027** · — · COMPLETED · sponsor: **Medical University of Silesia** · enrollment: 212 (actual)

## Conditions studied

- Sepsis
- Respiratory Failure
- Cardiac Arrest
- Circulatory Failure
- Critical Illness
- Sudden Cardiac Arrest

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07242027
- **Lead sponsor:** Medical University of Silesia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-21
- **Primary completion:** 2025-07-25
- **Final completion:** 2025-09-20
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07242027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07242027, "Use of Lactate-to-Albumin, CRP-to-Albumin, and Procalcitonin-to-Albumin Ratios to Predict Mortality in ICU Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07242027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*